{"id":"https://openalex.org/W4206579972","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214","title":"A phase 1b study of sotorasib, a specific and irreversible KRASG12C inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101).","display_name":"A phase 1b study of sotorasib, a specific and irreversible KRASG12C inhibitor, in combination with other anticancer therapies in advanced colorectal cancer (CRC) and other solid tumors (CodeBreaK 101).","publication_year":2022,"publication_date":"2022-01-19","ids":{"openalex":"https://openalex.org/W4206579972","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.4_suppl.tps214","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David S. Hong","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038339239","display_name":"Rona D. Yaeger","orcid":"https://orcid.org/0000-0002-7233-5454","observed_orcids":["https://orcid.org/0000-0002-7233-5454"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rona Yaeger","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060366426","display_name":"Yasutoshi Kuboki","orcid":"https://orcid.org/0000-0003-3675-953X","observed_orcids":["https://orcid.org/0000-0003-3675-953X"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasutoshi Kuboki","raw_affiliation_strings":["National Cancer Center Hospital East, Kashiwa, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital East, Kashiwa, Japan;","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031973387","display_name":"Toshiki Masuishi","orcid":"https://orcid.org/0000-0002-7521-1596","observed_orcids":["https://orcid.org/0000-0002-7521-1596"]},"institutions":[{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiki Masuishi","raw_affiliation_strings":["Aichi Cancer Center Hospital, Nagoya, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aichi Cancer Center Hospital, Nagoya, Japan;","institution_ids":["https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015591858","display_name":"Minal A. Barve","orcid":"https://orcid.org/0009-0007-4259-7457","observed_orcids":["https://orcid.org/0009-0007-4259-7457"]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minal A. Barve","raw_affiliation_strings":["Mary Crowley Cancer Research, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research, Dallas, TX;","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069777765","display_name":"Gerald Steven Falchook","orcid":"https://orcid.org/0000-0001-9165-2191","observed_orcids":["https://orcid.org/0000-0001-9165-2191"]},"institutions":[{"id":"https://openalex.org/I4210120438","display_name":"HealthONE","ror":"https://ror.org/032y5sx52","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120438"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald Steven Falchook","raw_affiliation_strings":["Sarah Cannon Research Institute at HealthONE, Denver, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute at HealthONE, Denver, CO;","institution_ids":["https://openalex.org/I4210120438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068824818","display_name":"Ramaswamy Govindan","orcid":"https://orcid.org/0000-0002-6964-9612","observed_orcids":["https://orcid.org/0000-0002-6964-9612"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramaswamy Govindan","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065605420","display_name":"Davendra P. S. Sohal","orcid":"https://orcid.org/0000-0002-0182-8403","observed_orcids":["https://orcid.org/0000-0002-0182-8403"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davendra Sohal","raw_affiliation_strings":["University of Cincinnati, Cincinnati, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati, Cincinnati, OH;","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077416215","display_name":"Pashtoon Murtaza Kasi","orcid":"https://orcid.org/0000-0002-5169-7085","observed_orcids":["https://orcid.org/0000-0002-5169-7085"]},"institutions":[{"id":"https://openalex.org/I2802216851","display_name":"University of Iowa Hospitals and Clinics","ror":"https://ror.org/04g2swc55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I126307644","https://openalex.org/I2802216851","https://openalex.org/I4210142782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pashtoon Murtaza Kasi","raw_affiliation_strings":["University of Iowa Hospitals and Clinics, Iowa City, IA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa Hospitals and Clinics, Iowa City, IA;","institution_ids":["https://openalex.org/I2802216851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043862738","display_name":"Timothy Francis Burns","orcid":"https://orcid.org/0000-0002-8685-3762","observed_orcids":["https://orcid.org/0000-0002-8685-3762"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy F. Burns","raw_affiliation_strings":["University of Pittsburgh Medical Center, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090256464","display_name":"Corey Jay Langer","orcid":"https://orcid.org/0000-0002-8483-6811","observed_orcids":["https://orcid.org/0000-0002-8483-6811"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey J. Langer","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059588535","display_name":"Sonam Puri","orcid":"https://orcid.org/0000-0001-8068-5051","observed_orcids":["https://orcid.org/0000-0001-8068-5051"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonam Puri","raw_affiliation_strings":["Huntsman Cancer Institute, Salt Lake City, UT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, Salt Lake City, UT;","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112732499","display_name":"Emily Chan","orcid":"https://orcid.org/0009-0008-7042-7217","observed_orcids":["https://orcid.org/0009-0008-7042-7217"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Chan","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111472717","display_name":"Pegah Jafarinasabian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pegah Jafarinasabian","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904661","display_name":"Gataree Ngarmchamnanrith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gataree Ngarmchamnanrith","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marko Rehn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marko Rehn","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022471623","display_name":"Qui Tran","orcid":"https://orcid.org/0000-0002-0760-964X","observed_orcids":["https://orcid.org/0000-0002-0760-964X"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qui Tran","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036091074","display_name":"David R. Gandara","orcid":"https://orcid.org/0000-0003-1784-048X","observed_orcids":["https://orcid.org/0000-0003-1784-048X"]},"institutions":[{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Gandara","raw_affiliation_strings":["UC Davis Comprehensive Cancer Center, Sacramento, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC Davis Comprehensive Cancer Center, Sacramento, CA;","institution_ids":["https://openalex.org/I4390039352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005968330","display_name":"John H. Strickler","orcid":"https://orcid.org/0000-0001-7579-1175","observed_orcids":["https://orcid.org/0000-0001-7579-1175"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H. Strickler","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061200817","display_name":"Marwan Fakih","orcid":"https://orcid.org/0000-0002-6554-5488","observed_orcids":["https://orcid.org/0000-0002-6554-5488"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marwan Fakih","raw_affiliation_strings":["City of Hope, Duarte, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA;","institution_ids":["https://openalex.org/I1301076528"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":17,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"4_suppl","first_page":"TPS214","last_page":"TPS214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/kras-g12c-mutation","display_name":"KRAS G12C mutation","score":0.9070000052452087},{"id":"https://openalex.org/keywords/advanced-colorectal-cancer","display_name":"advanced colorectal cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6179999709129333},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.8429999947547913},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9179999828338623},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.6579999923706055},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6710000038146973},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9129999876022339},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9190651774406433},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.8493523597717285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8348385095596313},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.6701539158821106},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6582053303718567},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5867876410484314},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5156096816062927},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4890952706336975},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4563252925872803},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45221084356307983},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.42965254187583923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42460185289382935},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.41950953006744385},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41499263048171997},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.3867682218551636},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38535797595977783},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31622183322906494},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2839696407318115},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.15687066316604614},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06731975078582764},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.06233030557632446},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.4_suppl.tps214","doi":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.4_suppl.tps214","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4295837306","https://openalex.org/W3167619469","https://openalex.org/W3119485904","https://openalex.org/W4200195771","https://openalex.org/W4295817512","https://openalex.org/W4391090980","https://openalex.org/W4406869727","https://openalex.org/W4390582065","https://openalex.org/W4281623889","https://openalex.org/W4310753291"],"abstract_inverted_index":{"TPS214":[0],"Background:":[1],"Approximately":[2],"3%":[3],"of":[4,58,106,239,249],"patients":[5,219],"(pts)":[6],"with":[7,52,60,112,120,145,207],"CRC":[8,85,121,161],"have":[9],"the":[10,30],"oncogenic":[11],"Kirsten":[12],"rat":[13],"sarcoma":[14],"viral":[15],"oncogene":[16],"homolog":[17],"(KRAS)":[18],"p.G12C":[19,114,148,209],"mutation.":[20],"Sotorasib,":[21],"a":[22,45,131],"small":[23],"molecule":[24],"that":[25],"specifically":[26],"and":[27,40,74,88,104,139,152,181,187,217,228,242,254,261],"irreversibly":[28],"inhibits":[29],"KRAS":[31,53,113,147,208],"G12C":[32],"mutant":[33],"protein,":[34],"has":[35],"demonstrated":[36],"modest":[37],"clinical":[38],"activity":[39],"no":[41],"dose-limiting":[42,226],"toxicities":[43,227],"as":[44,65],"single":[46],"agent":[47],"in":[48,84,110,140,143,160,215],"heavily":[49],"pretreated":[50,218],"pts":[51,111,144],"p.G12C-mutated":[54],"CRC.":[55],"The":[56,91],"combination":[57,122,141,240],"sotorasib":[59,83,137,182],"other":[61,153],"anticancer":[62],"therapies,":[63],"such":[64],"EGFR":[66,277],"or":[67,196,203,230],"MEK":[68,297],"inhibitors,":[69],"may":[70],"enhance":[71],"antitumor":[72],"efficacy":[73,105,243],"counteract":[75],"potential":[76],"escape":[77],"mechanisms.":[78],"Other":[79],"attractive":[80],"partners":[81],"for":[82,271],"include":[86,162,201,225,236],"biologics":[87],"chemotherapy":[89],"combinations.":[90],"CodeBreaK":[92],"101":[93],"master":[94],"protocol":[95],"is":[96,130,265],"designed":[97],"to":[98,252],"evaluate":[99],"safety,":[100],"tolerability,":[101],"pharmacokinetics":[102],"(PK),":[103],"multiple":[107],"sotorasib-based":[108],"combinations":[109],"mutated":[115,149],"solid":[116,154,205],"tumors.":[117,155],"Key":[118,156,198],"subprotocols":[119],"treatment":[123],"arms":[124],"are":[125],"highlighted":[126],"here.":[127],"Methods:":[128],"This":[129],"phase":[132],"1b,":[133],"open-label":[134],"study":[135],"evaluating":[136],"alone":[138],"regimens":[142,157,241],"advanced":[146,202],"CRC,":[150],"NSCLC,":[151],"being":[158],"explored":[159],"(1)":[163],"Subprotocol":[164,176,189],"A:":[165],"Sotorasib":[166,178,191],"+":[167,179,183,185,192,194,286,288,293,295],"trametinib":[168],"(MEK":[169],"inhibitor)":[170],"+/-":[171],"panitumumab":[172,180,184],"(EGFR":[173],"inhibitor),":[174],"(2)":[175],"H:":[177],"FOLFIRI,":[186],"(3)":[188],"M:":[190],"bevacizumab-awwb":[193],"FOLFIRI":[195,283],"FOLFOX.":[197],"eligibility":[199],"criteria":[200],"metastatic":[204],"tumor":[206],"mutation":[210],"identified":[211],"through":[212],"molecular":[213],"testing":[214],"treatment-na\u00efve":[216],"depending":[220],"on":[221],"cohort.":[222],"Primary":[223],"endpoints":[224,235],"treatment-emergent":[229],"treatment-related":[231],"adverse":[232],"events.":[233],"Secondary":[234],"PK":[237],"profile":[238],"(objective":[244],"response,":[245,250,253],"disease":[246],"control,":[247],"duration":[248],"time":[251],"progression-free":[255],"survival":[256],"assessed":[257],"per":[258],"RECIST":[259],"1.1,":[260],"overall":[262],"survival).":[263],"Enrollment":[264],"ongoing.":[266],"Contact":[267],"Amgen":[268],"Medical":[269],"Information":[270],"more":[272],"information:":[273,304],"medinfo@amgen.com":[274],"(NCT04185883).":[275],"Abbreviations:":[276],"=":[278,284,291,298],"epidermal":[279],"growth":[280],"factor":[281],"receptor;":[282],"5-fluorouracil":[285,292],"leucovorin":[287,294],"irinotecan;":[289],"FOLFOX":[290],"oxaliplatin;":[296],"mitogen-activated":[299],"protein":[300],"kinase.":[301],"Clinical":[302],"trial":[303],"NCT04185883.":[305]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":8}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-01-25T00:00:00"}